by Stacey Johnson | Mar 23, 2018
With 570 stem cell clinics in the United States alone offering direct-to-consumer marketing of stem cell interventions and “clear grounds for concern that some of the companies we found are not compliant with federal regulations” (Knoepfler and Turner, Cell Stem...
by Stacey Johnson | Feb 23, 2018
If you follow amyotrophic lateral sclerosis (ALS) research, you may be interested to know that ALS Canada is holding a free webinar (registration link enclosed) on February 28 to explain how funds from the ALS #Icebucketchallenge from 2014 were spent. Do you remember...
by Samantha Yammine | Nov 23, 2017
With the extensive exploitation of regenerative medicine through the marketing and selling of unapproved stem cell “therapies” online, it was refreshing to hear an update about clinical trials for a legitimate stem cell therapy at the Till & McCulloch Meetings...
by Stacey Johnson | Nov 17, 2017
Timothy Caulfield is a crusader against pseudoscience and “scienceploitation” as he likes to call the field of exploiting science for marketing purposes. He was one of the speakers in a lunch time panel, at the recent Till & McCulloch Meetings, on ethical,...
by Hamideh Emrani | Nov 16, 2017
Imagine your hands lose their control and, all of a sudden, the glass of water you just took from the fridge slips and shatters on the ground. What could it be? “It is probably carpel tunnel syndrome,” says your family doctor. But you experience more problematic...
by Hamideh Emrani | Nov 16, 2017
This year, Dr. Harold Atkins was honored with the Till & McCulloch Award. He and Dr. Mark Freedman led a clinical trial that used stem cells to reset the immune system as a treatment strategy for Multiple Sclerosis (MS) and a few other neurodegenerative...
Comments